162 related articles for article (PubMed ID: 25801552)
21. Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.
Salman S; Page-Sharp M; Batty KT; Kose K; Griffin S; Siba PM; Ilett KF; Mueller I; Davis TM
Antimicrob Agents Chemother; 2012 Jun; 56(6):3288-97. PubMed ID: 22470119
[TBL] [Abstract][Full Text] [Related]
22. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay.
Teja-Isavadharm P; Nosten F; Kyle DE; Luxemburger C; Ter Kuile F; Peggins JO; Brewer TG; White NJ
Br J Clin Pharmacol; 1996 Nov; 42(5):599-604. PubMed ID: 8951191
[TBL] [Abstract][Full Text] [Related]
23. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
[TBL] [Abstract][Full Text] [Related]
25. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Ramharter M; Kurth FM; Bélard S; Bouyou-Akotet MK; Mamfoumbi MM; Agnandji ST; Missinou MA; Adegnika AA; Issifou S; Cambon N; Heidecker JL; Kombila M; Kremsner PG
J Antimicrob Chemother; 2007 Nov; 60(5):1091-6. PubMed ID: 17884832
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics/Pharmacodynamics findings after repeated administration of ARTESUNATE thermostable suppositories (RECTOCAPS) in Vietnamese patients with uncomplicated malaria.
Benakis A; Binh TQ; Keundjian A; Scheiwe MW
Eur J Drug Metab Pharmacokinet; 2006; 31(1):41-5. PubMed ID: 16715782
[TBL] [Abstract][Full Text] [Related]
28. Comparison of in vitro/in vivo blood distribution and pharmacokinetics of artemisinin, artemether and dihydroartemisinin in rats.
Dai T; Jiang W; Guo Z; Xie Y; Dai R
J Pharm Biomed Anal; 2019 Jan; 162():140-148. PubMed ID: 30240987
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.
Falade C; Makanga M; Premji Z; Ortmann CE; Stockmeyer M; de Palacios PI
Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):459-67. PubMed ID: 15837358
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
[TBL] [Abstract][Full Text] [Related]
31. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
[TBL] [Abstract][Full Text] [Related]
32. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
Parashar D; Aditya NP; Murthy RS
Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.
Abdulla S; Sagara I; Borrmann S; D'Alessandro U; González R; Hamel M; Ogutu B; Mårtensson A; Lyimo J; Maiga H; Sasi P; Nahum A; Bassat Q; Juma E; Otieno L; Björkman A; Beck HP; Andriano K; Cousin M; Lefèvre G; Ubben D; Premji Z
Lancet; 2008 Nov; 372(9652):1819-27. PubMed ID: 18926569
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic properties of the antimalarial combination therapy artemether-lumefantrine in normal-weight, overweight and obese healthy male adults.
Sugiarto SR; Page-Sharp M; Drinkwater JJ; Davis WA; Salman S; Davis TME
Int J Antimicrob Agents; 2022 Jan; 59(1):106482. PubMed ID: 34818520
[TBL] [Abstract][Full Text] [Related]
35. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
Karunajeewa HA; Ilett KF; Dufall K; Kemiki A; Bockarie M; Alpers MP; Barrett PH; Vicini P; Davis TM
Antimicrob Agents Chemother; 2004 Aug; 48(8):2966-72. PubMed ID: 15273107
[TBL] [Abstract][Full Text] [Related]
36. Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.
Gignoux E; Azman AS; de Smet M; Azuma P; Massaquoi M; Job D; Tiffany A; Petrucci R; Sterk E; Potet J; Suzuki M; Kurth A; Cannas A; Bocquin A; Strecker T; Logue C; Pottage T; Yue C; Cabrol JC; Serafini M; Ciglenecki I
N Engl J Med; 2016 Jan; 374(1):23-32. PubMed ID: 26735991
[TBL] [Abstract][Full Text] [Related]
37. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
38. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Xing J; Bai KH; Liu T; Wang RL; Zhang LF; Zhang SQ
Xenobiotica; 2011 Mar; 41(3):252-8. PubMed ID: 21175296
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and bioavailability of oral and intramuscular artemether.
Karbwang J; Na-Bangchang K; Congpuong K; Molunto P; Thanavibul A
Eur J Clin Pharmacol; 1997; 52(4):307-10. PubMed ID: 9248770
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
